Xconomy National

Archives

by in

Entry	Author	Date	Location
Radius Health Seeks $86M IPO	Arlene Weintraub	02/07/12	Boston
Allozyne “Redistributes” Workforce After Scrapping Poniard Merger Plan	Luke Timmerman	01/03/12	Seattle
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles	Luke Timmerman	12/23/11	Seattle
Acceleron Pharma Lands $30,000,000 New Financing	VentureDeal	12/23/11	Boston
Allozyne Receives New Round	VentureDeal	12/23/11	Seattle
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy	Luke Timmerman	12/22/11	Seattle
Rhythm Adds Former Merck VP as CEO	Erin Kutz	11/09/11	Boston
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity	Arlene Weintraub	10/25/11	Boston
How Will Your Doctor Use Your Genome? Ask Our Panel Oct. 24	Luke Timmerman	10/12/11	San Francisco
Cardiac Dimensions Wins EU Approval for Heart Failure Device, Aims for Market in 2012	Luke Timmerman	09/29/11	Seattle
Valeritas Raises $150M for Insulin Device	Arlene Weintraub	09/13/11	New York
Theraclone Snaps Up $10.6M Financing	Luke Timmerman	09/08/11	Seattle
Theraclone Sciences Secures $10,600,000 Series B Round	VentureDeal	09/08/11	Seattle
BuyWithMe Gets Edhance, LogMeIn Picks Up Pachube, Polaris Backs Two MA Companies, & More Boston-Area Deals News	Erin Kutz	07/20/11	Boston
Nevro Raises $58M for Anti-Pain Device	Wade Roush	07/20/11	San Francisco
Nevro Lands $58,000,000 New Financing	VentureDeal	07/20/11	San Francisco
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News	Erin Kutz	07/15/11	Boston
Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors	Arlene Weintraub	07/14/11	Boston
Verastem Obtains $32,000,000 Series B Financing Round	VentureDeal	07/14/11	Boston
Allozyne Looks to Rustle Up Interest on Wall Street With Backdoor IPO	Luke Timmerman	07/13/11	Seattle
Termeer Joins Verastem Board	Luke Timmerman	06/13/11	Boston
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing	Arlene Weintraub	05/24/11	Boston
23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma	Luke Timmerman	05/24/11	San Francisco
Radius Health Obtains $91,000,000 New Funding	VentureDeal	05/24/11	Boston
Pacira Raises Wall Street Expectations of a New Blockbuster Painkiller	Arlene Weintraub	05/19/11	New York
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives	Luke Timmerman	05/13/11	San Francisco
BayBio’s Annual Conference, Tweet by Tweet	Luke Timmerman	04/22/11	San Francisco
Zacharon Aligns with Pfizer, Conatus Raises Big Bucks, Software Veteran Wins Wireless Institute Challenge, & More San Diego Life Sciences News	Bruce V. Bigelow	04/14/11	San Diego
The New Tech Bubble, Biotech Vs. Big Pharma, and More Thoughts from Boston BD Conference	Gregory T. Huang	04/14/11	Boston
Conatus Adds $7.5M, Closes Series B Round	Bruce V. Bigelow	04/13/11	San Diego
Page 1 of 6	next page »